{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:39:45Z","timestamp":1753893585100,"version":"3.41.2"},"reference-count":32,"publisher":"Sociedade Brasileira de Cardiologia","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,12]]},"DOI":"10.36660\/abc.20210933","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T12:28:39Z","timestamp":1681388919000},"source":"Crossref","is-referenced-by-count":3,"title":["SLC26A4-AS1 Agrava a Hipertrofia Card\u00edaca Induzida por AngII Aumentando a Express\u00e3o de SLC26A4"],"prefix":"10.36660","volume":"120","author":[{"given":"Xiaoliang","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-2246","authenticated-orcid":false,"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinjiong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"7","key":"key20230413082831_B1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of Physiological and Pathological Cardiac Hypertrophy","volume":"15","author":"Nakamura","year":"2018","unstructured":"1. Nakamura M, Sadoshima J. Mechanisms of Physiological and Pathological Cardiac Hypertrophy. Nat Rev Cardiol. 2018;15(7):387-407. doi: 10.1038\/s41569-018-0007-y.","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"key20230413082831_B2","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.116.304937","article-title":"Mechanotransduction in Cardiac Hypertrophy and Failure","volume":"116","author":"Lyon","year":"2015","unstructured":"2. Lyon RC, Zanella F, Omens JH, Sheikh F. Mechanotransduction in Cardiac Hypertrophy and Failure. Circ Res. 2015;116(8):1462-76. doi: 10.1161\/CIRCRESAHA.116.304937.","journal-title":"Circ Res"},{"key":"key20230413082831_B3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yjmcc.2016.06.001","article-title":"Physiological and Pathological Cardiac Hypertrophy","volume":"97","author":"Shimizu","year":"2016","unstructured":"3. Shimizu I, Minamino T. Physiological and Pathological Cardiac Hypertrophy. J Mol Cell Cardiol. 2016;97:245-62. doi: 10.1016\/j.yjmcc.2016.06.001.","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"key20230413082831_B4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/1566524019666190204112753","article-title":"GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice","volume":"18","author":"Zhang","year":"2018","unstructured":"4. Zhang C, Wang Y, Ge Z, Lin J, Liu J, Yuan X, et al. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice. Curr Mol Med. 2018;18(10):661-71. doi: 10.2174\/1566524019666190204112753.","journal-title":"Curr Mol Med"},{"key":"key20230413082831_B5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.12659\/MSMBR.900437","article-title":"Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis","volume":"22","author":"Samak","year":"2016","unstructured":"5. Samak M, Fatullayev J, Sabashnikov A, Zeriouh M, Schmack B, Farag M, et al. Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis. Med Sci Monit Basic Res. 2016;22:75-9. doi: 10.12659\/MSMBR.900437.","journal-title":"Med Sci Monit Basic Res"},{"issue":"2","key":"key20230413082831_B6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41576-019-0184-5","article-title":"Regulation of Gene Expression by Cis-Acting Long Non-Coding RNAs","volume":"21","author":"Gil","year":"2020","unstructured":"6. Gil N, Ulitsky I. Regulation of Gene Expression by Cis-Acting Long Non-Coding RNAs. Nat Rev Genet. 2020;21(2):102-17. doi: 10.1038\/s41576-019-0184-5.","journal-title":"Nat Rev Genet"},{"key":"key20230413082831_B7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.omtn.2017.12.018","article-title":"The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214","volume":"10","author":"Lv","year":"2018","unstructured":"7. Lv L, Li T, Li X, Xu C, Liu Q, Jiang H, et al. The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214. Mol Ther Nucleic Acids. 2018;10:387-97. doi: 10.1016\/j.omtn.2017.12.018.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"13","key":"key20230413082831_B8","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1111\/jcmm.15073","article-title":"SP1-Induced SNHG14 Aggravates Hypertrophic Response in in Vitro Model of Cardiac Hypertrophy via Up-Regulation of PCDH17","volume":"24","author":"Long","year":"2020","unstructured":"8. Long Y, Wang L, Li Z. SP1-Induced SNHG14 Aggravates Hypertrophic Response in in Vitro Model of Cardiac Hypertrophy via Up-Regulation of PCDH17. J Cell Mol Med. 2020;24(13):7115-26. doi: 10.1111\/jcmm.15073.","journal-title":"J Cell Mol Med"},{"key":"key20230413082831_B9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejphar.2017.11.031","article-title":"LncRNA Myocardial Infarction-Associated Transcript (MIAT) Contributed to Cardiac Hypertrophy by Regulating TLR4 via miR-93","volume":"818","author":"Li","year":"2018","unstructured":"9. Li Y, Wang J, Sun L, Zhu S. LncRNA Myocardial Infarction-Associated Transcript (MIAT) Contributed to Cardiac Hypertrophy by Regulating TLR4 via miR-93. Eur J Pharmacol. 2018;818:508-17. doi: 10.1016\/j.ejphar.2017.11.031.10.","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"key20230413082831_B10","doi-asserted-by":"crossref","first-page":"10827","DOI":"10.18632\/oncotarget.7312","article-title":"Construction and Analysis of Cardiac Hypertrophy-Associated lncRNA-mRNA Network Based on Competitive Endogenous RNA Reveal Functional lncRNAs in Cardiac Hypertrophy","volume":"7","author":"Song","year":"2016","unstructured":"10. Song C, Zhang J, Liu Y, Pan H, Qi HP, Cao YG, et al. Construction and Analysis of Cardiac Hypertrophy-Associated lncRNA-mRNA Network Based on Competitive Endogenous RNA Reveal Functional lncRNAs in Cardiac Hypertrophy. Oncotarget. 2016;7(10):10827-40. doi: 10.18632\/oncotarget.7312.","journal-title":"Oncotarget"},{"issue":"13","key":"key20230413082831_B11","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.4155\/fmc.15.107","article-title":"miRNA Therapeutics: A New Class of Drugs with Potential Therapeutic Applications in the Heart","volume":"7","author":"Bernardo","year":"2015","unstructured":"11. Bernardo BC, Ooi JY, Lin RC, McMullen JR. miRNA Therapeutics: A New Class of Drugs with Potential Therapeutic Applications in the Heart. Future Med Chem. 2015;7(13):1771-92. doi: 10.4155\/fmc.15.107.","journal-title":"Future Med Chem"},{"key":"key20230413082831_B12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA Translation and Stability by MicroRNAs","volume":"79","author":"Fabian","year":"2010","unstructured":"12. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA Translation and Stability by MicroRNAs. Annu Rev Biochem. 2010;79:351-79. doi: 10.1146\/annurev-biochem-060308-103103.","journal-title":"Annu Rev Biochem"},{"key":"key20230413082831_B13","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms2090","article-title":"The miRNA-212\/132 Family Regulates Both Cardiac Hypertrophy and Cardiomyocyte Autophagy","volume":"3","author":"Ucar","year":"2012","unstructured":"13. Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S, et al. The miRNA-212\/132 Family Regulates Both Cardiac Hypertrophy and Cardiomyocyte Autophagy. Nat Commun. 2012;3:1078. doi: 10.1038\/ncomms2090.","journal-title":"Nat Commun"},{"issue":"9","key":"key20230413082831_B14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12012-021-09667-w","article-title":"MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy","volume":"21","author":"Xu","year":"2021","unstructured":"14. Xu X, Su YL, Shi JY, Lu Q, Chen C. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy. Cardiovasc Toxicol. 2021;21(9):759-71. doi: 10.1007\/s12012-021-09667-w.","journal-title":"Cardiovasc Toxicol"},{"issue":"8","key":"key20230413082831_B15","doi-asserted-by":"crossref","first-page":"13252","DOI":"10.1002\/jcp.27997","article-title":"miR-29a Attenuates Cardiac Hypertrophy Through Inhibition of PPAR\u03b4 Expression","volume":"234","author":"Zhang","year":"2019","unstructured":"15. Zhang S, Yin Z, Dai FF, Wang H, Zhou MJ, Yang MH, et al. miR-29a Attenuates Cardiac Hypertrophy Through Inhibition of PPAR\u03b4 Expression. J Cell Physiol. 2019;234(8):13252-62. doi: 10.1002\/jcp.27997.","journal-title":"J Cell Physiol"},{"key":"key20230413082831_B16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2018.06.866","article-title":"Characterization of LncRNA Expression Profile and Identification of Novel LncRNA Biomarkers to Diagnose Coronary Artery Disease","volume":"275","author":"Li","year":"2018","unstructured":"16. Li L, Wang L, Li H, Han X, Chen S, Yang B, et al. Characterization of LncRNA Expression Profile and Identification of Novel LncRNA Biomarkers to Diagnose Coronary Artery Disease. Atherosclerosis. 2018;275:359-67. doi: 10.1016\/j.atherosclerosis.2018.06.866.","journal-title":"Atherosclerosis"},{"key":"key20230413082831_B17","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.dib.2018.06.048","article-title":"Dataset for Regulation between lncRNAs and their Nearby Protein-Coding Genes in Human Cancers","volume":"19","author":"Liu","year":"2018","unstructured":"17. Liu Z, Dai J, Shen H. Dataset for Regulation between lncRNAs and their Nearby Protein-Coding Genes in Human Cancers. Data Brief. 2018;19:1902-6. doi: 10.1016\/j.dib.2018.06.048.","journal-title":"Data Brief"},{"issue":"7483","key":"key20230413082831_B18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature12986","article-title":"The Multilayered Complexity of ceRNA Crosstalk and Competition","volume":"505","author":"Tay","year":"2014","unstructured":"18. Tay Y, Rinn J, Pandolfi PP. The Multilayered Complexity of ceRNA Crosstalk and Competition. Nature. 2014;505(7483):344-52. doi: 10.1038\/nature12986.","journal-title":"Nature"},{"issue":"10075","key":"key20230413082831_B19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(16)31321-6","article-title":"Hypertrophic Obstructive Cardiomyopathy","volume":"389","author":"Veselka","year":"2017","unstructured":"19. Veselka J, Anavekar NS, Charron P. Hypertrophic Obstructive Cardiomyopathy. Lancet. 2017;389(10075):1253-67. doi: 10.1016\/S0140-6736(16)31321-6.","journal-title":"Lancet"},{"issue":"3","key":"key20230413082831_B20","first-page":"281","article-title":"LncRNA PEG10 Aggravates Cardiac Hypertrophy Through Regulating HOXA9","volume":"23","author":"Wen","year":"2019","unstructured":"20. Wen ZQ, Li SH, Shui X, Tang LL, Zheng JR, Chen L. LncRNA PEG10 Aggravates Cardiac Hypertrophy Through Regulating HOXA9. Eur Rev Med Pharmacol Sci. 2019;23(3 Suppl):281-6. doi: 10.26355\/eurrev_201908_18658.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"29","key":"key20230413082831_B21","doi-asserted-by":"crossref","first-page":"47565","DOI":"10.18632\/oncotarget.17735","article-title":"LncRNA TINCR Attenuates Cardiac Hypertrophy by Epigenetically Silencing CaMKII","volume":"8","author":"Shao","year":"2017","unstructured":"21. Shao M, Chen G, Lv F, Liu Y, Tian H, Tao R, et al. LncRNA TINCR Attenuates Cardiac Hypertrophy by Epigenetically Silencing CaMKII. Oncotarget. 2017;8(29):47565-73. doi: 10.18632\/oncotarget.17735.","journal-title":"Oncotarget"},{"issue":"7","key":"key20230413082831_B22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11626-019-00368-x","article-title":"LncRNA TUG1 Contributes To Cardiac Hypertrophy via Regulating miR-29b-3p","volume":"55","author":"Zou","year":"2019","unstructured":"22. Zou X, Wang J, Tang L, Wen Q. LncRNA TUG1 Contributes To Cardiac Hypertrophy via Regulating miR-29b-3p. In Vitro Cell Dev Biol Anim. 2019;55(7):482-90. doi: 10.1007\/s11626-019-00368-x.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"3","key":"key20230413082831_B23","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/jcp.29145","article-title":"Overexpression of Long Noncoding RNA SLC26A4-AS1 Inhibits the Epithelial-Mesenchymal Transition via the MAPK Pathway in Papillary Thyroid Carcinoma","volume":"235","author":"Wang","year":"2020","unstructured":"23. Wang DP, Tang XZ, Liang QK, Zeng XJ, Yang JB, Xu J. Overexpression of Long Noncoding RNA SLC26A4-AS1 Inhibits the Epithelial-Mesenchymal Transition via the MAPK Pathway in Papillary Thyroid Carcinoma. J Cell Physiol. 2020;235(3):2403-13. doi: 10.1002\/jcp.29145.","journal-title":"J Cell Physiol"},{"issue":"1","key":"key20230413082831_B24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/febs.15325","article-title":"Long Non Coding RNA SLC26A4-AS1 Exerts Antiangiogenic Effects in Human Glioma by Upregulating NPTX1 via NFKB1 Transcriptional Factor","volume":"288","author":"Li","year":"2021","unstructured":"24. Li H, Yan R, Chen W, Ding X, Liu J, Chen G, et al. Long Non Coding RNA SLC26A4-AS1 Exerts Antiangiogenic Effects in Human Glioma by Upregulating NPTX1 via NFKB1 Transcriptional Factor. FEBS J. 2021;288(1):212-8. doi: 10.1111\/febs.15325.","journal-title":"FEBS J"},{"key":"key20230413082831_B25","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8253","article-title":"Inhibiting SLC26A4 Reverses Cardiac Hypertrophy in H9C2 Cells and in Rats","volume":"8","author":"Tang","year":"2020","unstructured":"25. Tang L, Yu X, Zheng Y, Zhou N. Inhibiting SLC26A4 Reverses Cardiac Hypertrophy in H9C2 Cells and in Rats. PeerJ. 2020;8:e8253. doi: 10.7717\/peerj.8253.","journal-title":"PeerJ"},{"issue":"2","key":"key20230413082831_B26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000487204","article-title":"lncRNA UCA1 Is a Novel Regulator in Cardiomyocyte Hypertrophy through Targeting the miR-184\/HOXA9 Axis","volume":"8","author":"Zhou","year":"2018","unstructured":"26. Zhou G, Li C, Feng J, Zhang J, Fang Y. lncRNA UCA1 Is a Novel Regulator in Cardiomyocyte Hypertrophy through Targeting the miR-184\/HOXA9 Axis. Cardiorenal Med. 2018;8(2):130-9. doi: 10.1159\/000487204.","journal-title":"Cardiorenal Med"},{"key":"key20230413082831_B27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.carpath.2018.04.003","article-title":"Long Non-Coding RNA CHRF Facilitates Cardiac Hypertrophy Through Regulating Akt3 via miR-93","volume":"35","author":"Wo","year":"2018","unstructured":"27. Wo Y, Guo J, Li P, Yang H, Wo J. Long Non-Coding RNA CHRF Facilitates Cardiac Hypertrophy Through Regulating Akt3 via miR-93. Cardiovasc Pathol. 2018;35:29-36. doi: 10.1016\/j.carpath.2018.04.003.","journal-title":"Cardiovasc Pathol"},{"issue":"9","key":"key20230413082831_B28","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCRESAHA.112.300682","article-title":"MicroRNA-22 Regulates Cardiac Hypertrophy and Remodeling in Response to Stress","volume":"112","author":"Huang","year":"2013","unstructured":"28. Huang ZP, Chen J, Seok HY, Zhang Z, Kataoka M, Hu X, et al. MicroRNA-22 Regulates Cardiac Hypertrophy and Remodeling in Response to Stress. Circ Res. 2013;112(9):1234-43. doi: 10.1161\/CIRCRESAHA.112.300682.","journal-title":"Circ Res"},{"issue":"4","key":"key20230413082831_B29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/humc.2019.087","article-title":"MiR-625-5p Inhibits Cardiac Hypertrophy Through Targeting STAT3 and CaMKII","volume":"30","author":"Cai","year":"2019","unstructured":"29. Cai K, Chen H. MiR-625-5p Inhibits Cardiac Hypertrophy Through Targeting STAT3 and CaMKII. Hum Gene Ther Clin Dev. 2019;30(4):182-91. doi: 10.1089\/humc.2019.087.","journal-title":"Hum Gene Ther Clin Dev"},{"issue":"12","key":"key20230413082831_B30","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.prp.2018.09.008","article-title":"MicroRNA-301a-3p Suppressed the Progression of Hepatocellular Carcinoma via Targeting VGLL4","volume":"214","author":"Hu","year":"2018","unstructured":"30. Hu J, Ruan J, Liu X, Xiao C, Xiong J. MicroRNA-301a-3p Suppressed the Progression of Hepatocellular Carcinoma via Targeting VGLL4. Pathol Res Pract. 2018;214(12):2039-45. doi: 10.1016\/j.prp.2018.09.008.","journal-title":"Pathol Res Pract"},{"issue":"12","key":"key20230413082831_B31","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3254","article-title":"Long Non-Coding RNA CASC19 Facilitates Non-Small Cell Lung Cancer Cell Proliferation and Metastasis by Targeting the miR-301b-3p\/LDLR Axis","volume":"22","author":"Wang","year":"2020","unstructured":"31. Wang L, Lin C, Sun N, Wang Q, Ding X, Sun Y. Long Non-Coding RNA CASC19 Facilitates Non-Small Cell Lung Cancer Cell Proliferation and Metastasis by Targeting the miR-301b-3p\/LDLR Axis. J Gene Med. 2020;22(12):e3254. doi: 10.1002\/jgm.3254.","journal-title":"J Gene Med"},{"issue":"25","key":"key20230413082831_B32","doi-asserted-by":"crossref","first-page":"21046","DOI":"10.18632\/oncotarget.4124","article-title":"MicroRNA-301a-3p Promotes Pancreatic Cancer Progression via Negative Regulation of SMAD4","volume":"6","author":"Xia","year":"2015","unstructured":"32. Xia X, Zhang K, Cen G, Jiang T, Cao J, Huang K, et al. MicroRNA-301a-3p Promotes Pancreatic Cancer Progression via Negative Regulation of SMAD4. Oncotarget. 2015;6(25):21046-63. doi: 10.18632\/oncotarget.4124.","journal-title":"Oncotarget"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/abccardiol.org\/article\/slc26a4-as1-agrava-a-hipertrofia-cardiaca-induzida-por-angii-aumentando-a-expressao-de-slc26a4\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:12:26Z","timestamp":1747401146000},"score":1,"resource":{"primary":{"URL":"https:\/\/abccardiol.org\/article\/slc26a4-as1-agrava-a-hipertrofia-cardiaca-induzida-por-angii-aumentando-a-expressao-de-slc26a4\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,12]]}},"alternative-id":["10.36660\/abc.20210933"],"URL":"https:\/\/doi.org\/10.36660\/abc.20210933","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e20210933"}}